Swedencare (SECARE) Pre-close call summary
Event summary combining transcript, slides, and related documents.
Pre-close call summary
20 Mar, 2026Market and Operational Update
No significant impact from Middle East turmoil or global transport disruptions; business as usual in key markets.
Demand remains stable and strong across Europe, the U.S., and globally, with ongoing monitoring of potential cost impacts.
Q4 profitability was affected by one-offs, including higher Amazon marketing costs, ERP implementation interruptions, and inventory write-offs, but these effects are expected to diminish going forward.
ERP implementation is now complete, improving production efficiency at the NaturVet site, with no further impact expected on gross margin or volumes.
Participation in major industry events like Global Pet Expo and Veterinary Meeting & Expo supports market presence.
Segment Performance and Sales Trends
North America and Europe show strong online sales and new product launches, with improving ROI on Amazon and robust demand in pet retail and veterinary channels.
Pet retail presence expanded to over 500 stores, with continued growth and new distribution partnerships.
Walmart sales increased week by week through February, driven by a Q4 display campaign.
European online and pet retail segments report strong demand, especially on Amazon, zooplus, and with strong starts in Italy and the UK.
Pharma, contract manufacturing, and private label segments started the year strong in the EU and UK, with US expected to improve in Q2.
Financial Outlook and Profitability
Double-digit annual organic growth achieved and targeted, with Q1 expected to meet this goal.
Gross margin improved to 58.1% in 2025 from Q4’s 56.8%, driven by better production and price increases.
EBITDA margin rose to 19.0% in 2025 from 15.9% in Q4, with improved profitability and no material one-offs expected in the current period.
Net debt/EBITDA ratio decreased to 2.9 compared to Q4, with ongoing debt amortization.
No significant one-off costs anticipated, and positive effects from scalability and price increases are expected.
Latest events from Swedencare
- Double-digit organic growth in Q4, but profitability declined due to one-off costs and disruptions.SECARE
Q4 202512 Feb 2026 - Q2 revenue up 10% with margin gains, strong European growth, and strategic acquisitions.SECARE
Q2 20243 Feb 2026 - Q3 saw 9% organic growth, higher margins, and strong European and dental segment gains.SECARE
Q3 202419 Jan 2026 - Q3 2025 saw record growth, robust margins, and new targets for global expansion and profitability.SECARE
SEB Nordic Seminar presentation16 Jan 2026 - Q1 2025 delivered 7% revenue growth, strong cash flow, and key acquisitions for future expansion.SECARE
Q1 202523 Dec 2025 - Record sales and margins in 2024, with Europe and dental segments leading growth; NaturVet set for 2025 rebound.SECARE
Q4 202417 Dec 2025 - Record Q3 revenue and profitability, led by strong organic growth and U.S. retail expansion.SECARE
Q3 202514 Dec 2025 - Q2 2025 saw 3% sales growth and margin pressure, with double-digit growth expected in H2.SECARE
Q2 202516 Nov 2025